273 related articles for article (PubMed ID: 22237406)
41. Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.
Yellepeddi VK; Baker OJ
Clin Exp Dent Res; 2020 Apr; 6(2):225-235. PubMed ID: 32250566
[TBL] [Abstract][Full Text] [Related]
42. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.
Chattopadhyay R; Raghavan S; Rao GN
Redox Biol; 2017 Aug; 12():438-455. PubMed ID: 28319894
[TBL] [Abstract][Full Text] [Related]
43. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
Kang JW; Lee SM
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
[TBL] [Abstract][Full Text] [Related]
44. Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro.
Salas-Hernández A; Espinoza-Pérez C; Vivar R; Espitia-Corredor J; Lillo J; Parra-Flores P; Sánchez-Ferrer CF; Peiró C; Díaz-Araya G
Mol Biol Rep; 2021 Jan; 48(1):57-66. PubMed ID: 33459958
[TBL] [Abstract][Full Text] [Related]
45. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
Mottola G; Chatterjee A; Wu B; Chen M; Conte MS
PLoS One; 2017; 12(3):e0174936. PubMed ID: 28362840
[TBL] [Abstract][Full Text] [Related]
46. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.
Eickmeier O; Seki H; Haworth O; Hilberath JN; Gao F; Uddin M; Croze RH; Carlo T; Pfeffer MA; Levy BD
Mucosal Immunol; 2013 Mar; 6(2):256-66. PubMed ID: 22785226
[TBL] [Abstract][Full Text] [Related]
47. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models.
Meesawatsom P; Burston J; Hathway G; Bennett A; Chapman V
J Neuroinflammation; 2016 Sep; 13(1):233. PubMed ID: 27589850
[TBL] [Abstract][Full Text] [Related]
48. Immunohistopathology of Sjögren's syndrome.
Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
[TBL] [Abstract][Full Text] [Related]
49. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis.
Zhao YL; Zhang L; Yang YY; Tang Y; Zhou JJ; Feng YY; Cui TL; Liu F; Fu P
Chin Med J (Engl); 2016 May; 129(9):1100-7. PubMed ID: 27098797
[TBL] [Abstract][Full Text] [Related]
50. Exploring Salivary Epithelial Dysfunction in Sjögren's Disease.
Noll B; Beckman M; Bahrani Mougeot F; Mougeot JL
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732189
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.
Vosters JL; Landek-Salgado MA; Yin H; Swaim WD; Kimura H; Tak PP; Caturegli P; Chiorini JA
Arthritis Rheum; 2009 Dec; 60(12):3633-41. PubMed ID: 19950301
[TBL] [Abstract][Full Text] [Related]
52. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
53. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
54. ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation.
Nunes VS; Abrahão O; Rogério AP; Serhan CN
J Phys Chem B; 2023 Jul; 127(29):6479-6486. PubMed ID: 37428488
[TBL] [Abstract][Full Text] [Related]
55. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
[TBL] [Abstract][Full Text] [Related]
56. Laminin isoform profiles in salivary glands in Sjögren's syndrome.
Porola P; Mackiewicz Z; Laine M; Baretto G; Stegaev V; Takakubo Y; Takagi M; Ainola M; Konttinen YT
Adv Clin Chem; 2011; 55():35-59. PubMed ID: 22126023
[TBL] [Abstract][Full Text] [Related]
57. Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats.
Zhang T; Shu HH; Chang L; Ye F; Xu KQ; Huang WQ
Int Immunopharmacol; 2015 Sep; 28(1):322-7. PubMed ID: 26118631
[TBL] [Abstract][Full Text] [Related]
58. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
[TBL] [Abstract][Full Text] [Related]
59. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome.
Fox PC; Speight PM
Crit Rev Oral Biol Med; 1996; 7(2):144-58. PubMed ID: 8875029
[TBL] [Abstract][Full Text] [Related]
60. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]